National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	222,941 L.L
V07AB01	STERILE WATER FOR INJECTION	G	Water for injection -		Water for injection, irrigation	264,311 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%, Glucose - 5%		Injectable solution	158,587 L.L
V07AB01	STERILE WATER FOR INJECTION USP	G	Water for injection -		Water for injection, irrigation	203,405 L.L
V07AB01	STERILE WATER FOR INJECTION USP	G	Water for injection -		Water for injection, irrigation	264,311 L.L
V07AB01	STERILE WATER FOR IRRIGATION	G	Water for Irrigation -		Water for injection, irrigation	203,481 L.L
P03AX01	SPIDOGALE	G	Benzyl benzoate - 10g/100ml, Sulfur colloïdal - 5g/100ml		Lotion	207,336 L.L
A10BD07	SAGIMET	G	Metformin HCl - 1000mg, Sitagliptin (HCl monohydrate) - 50mg		Tablet, film coated	1,551,690 L.L
A10BD07	SITAMET	G	Metformin - 1000mg, Sitagliptin - 50mg		Tablet, film coated	2,444,896 L.L
A10BD07	SITAVITEA	G	Metformin - 1000mg, Sitagliptin - 50mg		Tablet, film coated	1,079,106 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	193,062 L.L
B05BB02	SERUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	180,421 L.L
A10BD07	SAGIMET	G	Metformin HCl - 500mg, Sitagliptin (HCl monohydrate) - 50mg		Tablet, film coated	1,432,536 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	236,731 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	211,449 L.L
A10BD07	SAGIMET	G	Metformin HCl - 850mg, Sitagliptin (HCl monohydrate) - 50mg		Tablet, film coated	1,463,892 L.L
A10BD07	SITAMET	G	Metformin - 850mg, Sitagliptin - 50mg		Tablet, film coated	2,301,079 L.L
D06BA51	SILVEZ PLUS	G	Silver sulfadiazine - , Chlorhexidine -		Cream	349,399 L.L
A10BD07	SITAVITEA	G	Metformin - 850mg, Sitagliptin - 50mg		Tablet, film coated	1,079,106 L.L
J07AL02	SYNFLORIX	B	Polysaccharide from each of 10 capsular types of pneumococcus (conjugated to carrier proteins) adsorbed onto aluminium phosphate - 1mcg/0.5ml, Polysaccharide of serotypes 41,2, 18C1,3 and 19F1,4 - 3mcg/0.5ml, 1 adsorbed onto aluminium phosphate - 0.5mg Al3+, 2 conjugated to protein D (derived from NTHi) carrier protein - ~ 13mcg, 3 conjugated to tetanos toxoid carrier protein - ~ 8mcg, 4 conjugated to diphteria toxoid carrier protein - ~ 5mcg		Injectable suspension	4,675,228 L.L
R01AD09	SINOCORT METERED DOSE	G	Mometasone furoate - 0.05%	0.05%	Spray, suspension	419,279 L.L
B05XA05	SULFATE DE MAGNESIUM PROAMP	G	Magnesium sulfate - 0.15g/ml	0.15g/ml	Injectable solution	1,400,284 L.L
M01AE03	SOLKET INFLAMMATION AND PAIN	G	Ketoprofen Lysine salt - 0.16%	0.16%	Spray	946,065 L.L
N04BC05	SIFROL	B	Pramipexole (dihydrochloride monohydrate) - 0.18mg	0.18mg	Tablet	631,606 L.L
H01CB02	SANDOSTATIN	B	Octreotide - 0.1mg/ml	0.1mg/ml	Injectable solution	1,038,790 L.L
D10AX03	SKINOREN	B	Azelaic acid - 0.2g/g	0.2g/g	Cream	722,987 L.L
N04BC05	SIFROL ER	B	Pramipexole (dihydrochloride monohydrate) - 0.375mg	0.375mg	Tablet, extended release	473,033 L.L
H01CB05	SIGNIFOR	B	Pasireotide (diaspartate) - 0.3mg/ml	0.3mg/ml	Injectable solution	168,719,438 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	133,856 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	149,393 L.L

National Cancer Registry (NCR)